Posts Tagged 'dpp-4 inhibitors'

FDA: DPP-4 Inhibitors Like Januvia May Cause Severe Joint Pain

fda issues warning on DPP-4 inhibitorsThe U.S. Food and Drug Administration (FDA) has issued a safety communication warning that certain type 2 diabetes drugs, called dipeptidyl peptidase-4 (DPP-4) inhibitors, may lead to severe joint pain in patients taking them. Among the diabetes drugs named in the announcement are Merck’s Januvia (sitagliptin) and AstraZeneca and Bristol-Myers Squibb’s Onglyza (saxagliptin); as well as Incretin mimetic drugs containing linagliptin or alogliptin.

Januvia was approved by the FDA ...

continue reading...